V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270018131 | 270014352 | 1.83 | 76.8 | Adjuvant (A) | 2019-02-19 | 2019-03-04 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015525 | FLUOROURACIL |
| 270018132 | 270009317 | 1.75 | 90.9 | Curative (C) | null | 2014-01-13 | DHAP | N | N | 270015527 | DHAP |
| 270018133 | 270009318 | null | null | Curative (C) | 2016-02-09 | 2016-02-09 | null | N | N | 270015528 | NOT MATCHED |
| 270018134 | 270009319 | 1.76 | 64.9 | Disease modification (D) | 2014-03-30 | 2014-04-02 | CHOP R | 02 | N | 270015528 | CHOP R |
| 270018135 | 270009322 | 1.71 | 65 | Curative (C) | 2017-04-01 | 2017-04-01 | CHOP R - 21 days | N | N | 270015534 | CHOP R |
| 270018136 | 270009330 | 1.6 | 90 | Curative (C) | 2014-05-26 | 2014-06-09 | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + TRIPTORELIN + VINBLASTINE | N | null | 270015545 | NOT MATCHED |
| 270018137 | 270014359 | 1.94 | 73 | Adjuvant (A) | 2017-03-19 | 2017-07-22 | Cetuximab + Radiotherapy Maint | 2 | N | 270015556 | CETUXIMAB + RT |
| 270018138 | 270009336 | null | 72.8 | Palliative (P) | null | 2017-03-16 | Bevacizumab + Oxaliplatin +MdG | 02 | null | 270015560 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018139 | 270009337 | null | null | null | 2018-03-03 | 2018-03-10 | CHOP R - 21 days | N | N | 270015562 | CHOP R |
| 270018140 | 270019930 | 1.79 | 57.2 | Adjuvant (A) | 2017-10-03 | 2017-10-03 | CHLVPP | N | N | 270015572 | CHLVPP |
| 270018141 | 270009343 | 1.74 | 64 | Neo-adjuvant (N) | 2014-08-14 | 2014-08-14 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270015578 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018142 | 270009345 | null | null | Curative (C) | 2014-08-30 | 2014-08-31 | null | N | N | 270015585 | NOT MATCHED |
| 270018143 | 270009355 | 1.69 | 70.2 | Curative (C) | 2013-08-19 | 2013-10-13 | CHLVPP | N | N | 270015616 | CHLVPP |
| 270018144 | 270009356 | 1.78 | 52.5 | Neo-adjuvant (N) | 2016-02-13 | 2018-11-25 | Capecitabine 42days + RT | 2 | N | 270015617 | CAPECITABINE + RT |
| 270018145 | 270009359 | 1.76 | 77 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-05 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270015624 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018147 | 270014376 | 1.55 | 66.7 | Palliative (P) | 2017-05-17 | 2017-07-04 | Capecitabine (14 day) + Irinotecan | N | N | 270015646 | CAPECITABINE + IRINOTECAN |
| 270018148 | 270009368 | 1.7 | 78.1 | Adjuvant (A) | 2018-07-06 | 2018-07-07 | FLUOROURACIL | 2 | N | 270015655 | FLUOROURACIL |
| 270018149 | 270009378 | null | 100.1 | Curative (C) | 2015-02-05 | 2018-09-06 | Cisplatin +Fluorouracil (3 wk) | N | N | 270015692 | CISPLATIN + FLUOROURACIL |
| 270018150 | 270016909 | 1.63 | null | Adjuvant (A) | 2015-12-25 | 2016-01-20 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + GEMCITABINE + VINCRISTINE | null | null | 270015700 | NOT MATCHED |
| 270018151 | 270014386 | null | 77.8 | Curative (C) | 2016-08-15 | 2016-11-11 | Cetuximab + Radiotherapy Maint | 99 | null | 270015714 | CETUXIMAB + RT |
| 270018152 | 270009383 | 1.8 | null | Curative (C) | 2017-04-23 | 2017-05-22 | CHOP R - 21 days | N | N | 270015716 | CHOP R |
| 270018153 | 270009384 | 1.76 | 67 | Neo-adjuvant (N) | 2015-02-09 | 2015-02-11 | CAPECITABINE + RT | 02 | N | 270015717 | CAPECITABINE + RT |
| 270018154 | 270009389 | 1.69 | 80 | Palliative (P) | 2014-10-14 | 2014-10-26 | Fluorouracil + Folinic Acid Weekly | 2 | N | 270015743 | FLUOROURACIL |
| 270018155 | 270009394 | 1.6 | 62.8 | Curative (C) | 2019-05-05 | 2019-05-24 | CHOP R - 21 days | 2 | N | 270015769 | CHOP R |
| 270018156 | 270009401 | 1.76 | 68.2 | Curative (C) | null | 2015-11-05 | DHAP | N | N | 270015795 | DHAP |
| 270018157 | 270009410 | 1.77 | 50 | Curative (C) | 2017-12-19 | 2017-12-26 | CHLVPP | 2 | N | 270015818 | CHLVPP |
| 270018158 | 270014399 | 1.7 | 78 | Palliative (P) | 2017-09-23 | 2017-09-23 | CHOP R | 02 | N | 270015819 | CHOP R |
| 270018159 | 270009418 | null | 71 | Adjuvant (A) | 2015-03-18 | 2015-03-18 | Capecitabine (14 day) + Irinotecan | N | N | 270015843 | CAPECITABINE + IRINOTECAN |
| 270018160 | 270014405 | null | null | Palliative (P) | 2016-02-01 | 2016-10-05 | CHLVPP | null | null | 270015860 | CHLVPP |
| 270018161 | 270009426 | null | 60.7 | Disease modification (D) | 2015-03-17 | 2015-10-12 | CHOP R | 2 | N | 270015867 | CHOP R |
| 270018162 | 270009429 | 1.75 | 109 | Curative (C) | 2018-09-07 | 2018-09-08 | DHAP | N | N | 270015870 | DHAP |
| 270018163 | 270009430 | 1.9 | 75 | Palliative (P) | 2018-05-03 | 2018-05-04 | Capecitabine (14 day) + Irinotecan | N | Y | 270015882 | CAPECITABINE + IRINOTECAN |
| 270018164 | 270009431 | 1.57 | 73 | Palliative (P) | 2016-11-11 | 2017-12-01 | CHLVPP | N | N | 270015884 | CHLVPP |
| 270018165 | 270009433 | 1.8 | 100 | Curative (C) | 2015-03-01 | 2015-11-30 | Shamash LBCMVD-56 | N | N | 270015886 | NOT MATCHED |
| 270018166 | 270009435 | 1.62 | 48.1 | Neo-adjuvant (N) | 2014-06-16 | 2014-06-22 | Bevacizumab + Oxaliplatin +MdG | N | null | 270015891 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018167 | 270009441 | 1.59 | 58.6 | Palliative (P) | 2016-01-06 | 2016-02-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | 270015908 | FLUOROURACIL |
| 270018169 | 270009447 | 1.74 | 91 | Adjuvant (A) | 2017-04-26 | 2017-04-28 | FLUOROURACIL | N | null | 270015929 | FLUOROURACIL |
| 270018170 | 270009450 | 1.65 | 64 | Palliative (P) | 2018-09-18 | 2018-09-26 | Trifluridine + Tipiracil | 02 | N | 270015930 | TRIFLURIDINE + TIPIRACIL |
| 270018171 | 270009456 | 1.93 | null | Curative (C) | 2014-04-21 | 2014-08-14 | DHAP | null | null | 270015948 | DHAP |
| 270018172 | 270009461 | null | null | Curative (C) | 2015-05-10 | 2015-05-10 | CHLVPP | null | null | 270015957 | CHLVPP |
| 270018173 | 270009466 | 1.61 | 71.2 | Curative (C) | 2013-12-10 | 2013-12-10 | CHLVPP | N | N | 270015970 | CHLVPP |
| 270018174 | 270009467 | 1.62 | 66 | Curative (C) | 2017-02-25 | 2017-03-04 | Shamash LBCMVD-56 | N | N | 270015974 | NOT MATCHED |
| 270018175 | 270009468 | 1.82 | 105 | Not known (9) | 2016-02-13 | 2016-02-23 | Fluorouracil + Folinic Acid (Mayo) | N | N | 270015980 | FLUOROURACIL |
| 270018176 | 270014428 | 1.79 | 95.4 | Not known (9) | null | 2015-09-15 | CISPLATIN + FLUOROURACIL | N | null | 270015983 | CISPLATIN + FLUOROURACIL |
| 270018177 | 270009476 | 1.74 | 77.8 | Disease modification (D) | 2017-08-31 | 2017-09-07 | CHLVPP | 02 | Y | 270015993 | CHLVPP |
| 270018178 | 270018395 | 1.77 | 68 | Palliative (P) | 2014-03-22 | 2014-03-28 | CHLVPP | N | N | 270016003 | CHLVPP |
| 270018179 | 270016948 | 1.77 | 82.6 | Curative (C) | 2015-02-09 | 2016-08-29 | CHLVPP | N | N | 270016013 | CHLVPP |
| 270018180 | 270009483 | null | null | Neo-adjuvant (N) | 2014-01-10 | 2014-01-10 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270016016 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270018181 | 270019680 | 1.82 | 101.2 | Curative (C) | 2016-02-05 | 2018-12-06 | Trifluridine + Tipiracil | N | N | 270016033 | TRIFLURIDINE + TIPIRACIL |
| 270018182 | 270020082 | null | 62.2 | Neo-adjuvant (N) | null | 2017-10-18 | CAPECITABINE + RT | null | N | 270016041 | CAPECITABINE + RT |